Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Bazzill

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nanomedicine (London, England)|March 1, 2017
Vaccine nanoparticles for protection against HIV infectionMarisa E Aikins, Joseph Bazzill, James J Moon
ACS Medicinal Chemistry Letters|November 26, 2013
Synthesis and Cytotoxicity of Semisynthetic Withalongolide A AnaloguesHashim F Motiwala, Joseph Bazzill, Abbas Samadi, et al.
Surgery|November 20, 2012
Novel withanolides target medullary thyroid cancer through inhibition of both RET phosphorylation and the mammalian target of rapamycin pathwayAbbas K Samadi, Joseph Bazzill, Xuan Zhang, et al.
Journal of Natural Products|December 21, 2012
Antiproliferative withanolides from Datura wrightiiHuaping Zhang, Joseph Bazzill, Robert J Gallagher, et al.
Medchemcomm|October 21, 2014
Triazole Containing Novobiocin and Biphenyl Amides as Hsp90 C-Terminal InhibitorsJinbo Zhao, Huiping Zhao, Jessica A Hall, et al.
Molecular Oncology|April 8, 2020
Novel C-terminal heat shock protein 90 inhibitors target breast cancer stem cells and block migration, self-renewal, and epithelial-mesenchymal transitionChitra Subramanian, Patrick T Grogan, Ton Wang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nanomedicine (London, England)|March 1, 2017
Vaccine nanoparticles for protection against HIV infectionMarisa E Aikins, Joseph Bazzill, James J Moon
ACS Medicinal Chemistry Letters|November 26, 2013
Synthesis and Cytotoxicity of Semisynthetic Withalongolide A AnaloguesHashim F Motiwala, Joseph Bazzill, Abbas Samadi, et al.
Surgery|November 20, 2012
Novel withanolides target medullary thyroid cancer through inhibition of both RET phosphorylation and the mammalian target of rapamycin pathwayAbbas K Samadi, Joseph Bazzill, Xuan Zhang, et al.
Journal of Natural Products|December 21, 2012
Antiproliferative withanolides from Datura wrightiiHuaping Zhang, Joseph Bazzill, Robert J Gallagher, et al.
Medchemcomm|October 21, 2014
Triazole Containing Novobiocin and Biphenyl Amides as Hsp90 C-Terminal InhibitorsJinbo Zhao, Huiping Zhao, Jessica A Hall, et al.
Molecular Oncology|April 8, 2020
Novel C-terminal heat shock protein 90 inhibitors target breast cancer stem cells and block migration, self-renewal, and epithelial-mesenchymal transitionChitra Subramanian, Patrick T Grogan, Ton Wang, et al.
Pageof 1